TCTR20201219001招募中4 期
Efficacy of medium cut-off membrane hemodialysis on middle molecule uremic toxins reduction as comparable with mixed-dilution online HDF : Prospective cross-over study
The Kidney Foundation of Thailand0 个研究点目标入组 14 人开始时间: 2020年12月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 90 Years(—)
- 性别
- All
入选标准
- •1.Thai ESRD patient 18-90 year
- •2.Hemodialysis at KCMH 3/weeks
- •3.Hemodialysis 3/weeks with Kt/V >/= 1.2
- •4.Residual renal function < 100ml/day
- •5.Using AVF or AVG with blood flow rate >/= 400 ml/min
- •6.Optimal dry weight
- •7.Hemodynamic stable at least 2 weeks before enrollment
排除标准
- •1.Severe infection
- •2.Severe CVD
- •3.Advanced stage malignancy
- •4.Advanced stage cirrhosis CTP B to C
- •5.Malnutrition
- •6.Pregnancy
- •7.Hemodynamic instability < 2 weeks before enrollment
- •8.Contraindication for anticoagulants
- •9.Deny informed consent
研究者
相似试验
已完成
不适用
A comparison of removal of therapy in hemodialysis using medium cut-off dialysisKCT0003009Yonsei University Health System, Gangnam Severance Hospital6
已完成
不适用
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40
已完成
不适用
A trial of low-efficient hemofiltration and hemodialysis in the intracranial hypertension of acute phase in hemodialysis patientsintracranial hypertensionJPRN-UMIN000005621Division of Nephrology, Hypertension and Endocrinology, Itabashi Hospital, Nihon University School of Medicine20
已完成
不适用
Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathyBullous keratopathyJPRN-UMIN000021478Kurume University30
已完成
不适用
Comparison of MCO HD on Markers of Vascular Health Compared With On-Line HaemodiafiltrationEnd Stage Renal DiseaseCardiovascular DiseasesInflammationNCT03510520Manchester University NHS Foundation Trust63
